跳至主要内容
临床试验/NCT04756154
NCT04756154已完成3 期

Assessment of the Antimicrobial Efficacy of 3M™ SoluPrep™ Preoperative Skin Preparation Against Resident Human Skin Flora on the Inguinal Region

Solventum US LLC1 个研究点 分布在 1 个国家目标入组 154 人开始时间: 2020年7月6日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
3 期
状态
已完成
入组人数
154
试验地点
1
主要终点
Log Change (Reduction) in Skin Flora on the Inguinal Region at 6 Hours

研究概览

简要总结

The purpose of this study is to determine the antimicrobial efficacy of an investigational CHG/IPA prep on skin flora of the inguinal regions of human subjects.

详细描述

Non-inferiority of the investigational product to the FDA-approved active control for log10/cm2 recovery of skin flora relative to Treatment Day baseline log10/cm2 on the inguinal region at 10 minutes following application. Non-inferiority is based on a non-inferiority margin of 0.5 log10/cm2.

Superiority of the active products to the negative control for log10/cm2 recovery of skin flora relative to Treatment Day baseline log10/cm2 on the inguinal region at 10 minutes following application. A superiority margin of 1.2 log10/cm2 is used.

Number of observations for which the log10/cm2 recovery of skin flora on the inguinal region at 6 hours following application of the study products is higher than treatment day log10/cm2 baseline skin flora.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
Single (Outcomes Assessor)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Subjects of any race
  • Subjects in good health
  • Minimum skin flora baseline requirements on inguinal region

排除标准

  • Any tattoos, scars, breaks in the skin, or any form of dermatitis, or other skin disorders (including acne) on the applicable test area
  • Topical antimicrobial exposure within 14 days prior to screening and treatment days
  • Use of systemic or topical antibiotics, steroid medications, or any other products known to affect the normal microbial flora of the skin within 14 days prior to screening and treatment days

研究组 & 干预措施

CHG/IPA Surgical skin preparation

Experimental

Apply topically to the inguinal region for 2 minutes

干预措施: CHG/IPA Surgical skin preparation (Drug)

CHG/IPA Film-Forming Surgical skin preparation

Active Comparator

Apply topically to the inguinal region for 2 minutes

干预措施: CHG/IPA Surgical skin preparation (Drug)

Normal saline

Placebo Comparator

Apply topically to the inguinal region for 2 minutes

干预措施: Normal saline (Drug)

结局指标

主要结局

Log Change (Reduction) in Skin Flora on the Inguinal Region at 6 Hours

时间窗: 6 hours

Persistent efficacy endpoint which is a binary endpoint with success/failure, where "success" is defined as log10 CFU/cm2 of skin flora on the inguinal region at 6 hours following application of the study products being lower than the treatment day baseline skin flora

Log Change (Reduction) in Skin Flora on the Inguinal Region at 10 Minutes

时间窗: 10 minutes

Immediate efficacy endpoint which is defined as the average treatment effect (ATE) log10 CFU/cm2 of skin flora on the inguinal region at 10 minutes following application of the study products relative to the treatment day baseline skin flora

次要结局

未报告次要终点

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验